TYLER VAN CURA: Open Payments
NPI 1336827120 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
Products named: WINREVAIR, Wegovy, FARXIGA, OPSUMIT, ZEPBOUND, FUROSCIX.
Industry payments across NY — which companies pay providers there.
